A comparison of the theory of unpleasant symptoms and the conceptual model of chemotherapy-related changes in cognitive function

Oncology Nursing Forum

Volumn 36, Issue 1, 2009, Pages

  Myers, Jamie S ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL NURSING RESEARCH; COGNITIVE DEFECT; COMORBIDITY; COMPARATIVE STUDY; HUMAN; MIDDLE AGED; NEOPLASM; NURSING; ONCOLOGY NURSING; PROSPECTIVE STUDY; PSYCHOANALYTIC THEORY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; QUALITY OF LIFE; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CLINICAL NURSING RESEARCH; COGNITION DISORDERS; COMORBIDITY; HUMANS; MIDDLE AGED; MODELS, PSYCHOLOGICAL; NEOPLASMS; ONCOLOGIC NURSING; PLEASURE-PAIN PRINCIPLE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 58149497145     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/09.ONF.E1-E10     Document Type: Article

References (45)

1. Ahles, T.A. & Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19(8), 812-820.
2. Ahles, T.A., & Saykin, A.J. (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3(Suppl. 3), S84-S90.
3. Ahles, T.A., & Saykin, A.J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews. Cancer, 7(3), 192-201.
4. Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
5. Barnes, D.E., Cauley, J.A., Lui, L.Y., Fink, H.A., McCulloch, C., Stone, K.L., et al. (2007). Women who maintain optimal cognitive function into old age. Journal of the American Geriatrics Society, 55(2), 259-264.
6. Barsevick, A.M. (2007). The elusive concept of the symptom cluster. Oncology Nursing Forum, 34(5), 971-980.
7. Brady, C.B., Spiro, A., III, & Gaziano, J.M. (2005). Effects of age and hypertension status on cognition: The Veterans Affairs Normative Aging Study. Neuropsychology, 19(6), 770-777.
8. Brown, K.A., Esper, P., Kelleher, L.O., O'Neill, J.E.B., Polovich, M., & White, J.M. (Eds.). (2001). Chemotherapy and biotherapy guidelines and recommendations for practice. Pittsburgh, PA: Oncology Nursing Society.
9. Chen, M.L., & Tseng, H.H. (2005). Identification and verification of symptom clusters in cancer patients. Journal of Supportive Oncology, 3(6, Suppl. 4), 28-29.
10. Chen, Y., Jungsuwadee, P., Vore, M., Butterfield, D.A., & St. Clair, D.K. (2007). Collateral damage in cancer chemotherapy: Oxidative stress in nontargeted tissues. Molecular Interventions, 7(3), 147-156.
11. Dantzer, R., & Kelly, K.W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21(2), 153-160.
12. Dodd, M., Janson, S., Facione, N., Faucett, J., Froelicher, E.S., Humphreys, J., et al. (2001). Advancing the science of symptom management. Journal of Advanced Nursing, 33(5), 668-676.
13. Dodd, M.J., Miaskowski, C., & Paul, S.M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 465-470.
14. Gift, A.G., Jablonski, A., Stommel, M., & Given, C.W. (2004). Symptom clusters in elderly patients with lung cancer. Oncology Nursing Forum, 31(2), 202-212.
15. Grady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C., & Barrett-Connor, E. (2002). Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/Progestin Replacement Study. American Journal of Medicine, 113(7), 543-548.
16. Hart, R.P., Wade, J.B., & Martelli, M.F. (2003). Cognitive impairment in patients with chronic pain: The significance of stress. Current Pain and Headache Reports, 7(2), 116-126.
17. Hess, L.M., & Insel, K.C. (2007). Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum, 34(5), 981-994.
18. Hillman, C.H., Motl, R.W., Pontifex, M.B., Posthuma, D., Stubbe, J.H., Boomsma, D.I., et al. (2006). Physical activity and cognitive function in a cross-section of younger and older community-dwelling individuals. Health Psychology, 25(6), 678-687.
19. Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32(6), 1151-1163.
20. Kim, H.J., McGuire, D.B., Tulman, L., & Barsevick, A.M. (2005). Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nursing, 28(4), 270-282.
21. Klemp, J.R., Stanton, A.L., Kimler, B.F., & Fabian, C.J. (2006). Evaluating the effects of chemotherapy on cognitive function and quality of life in pre-menopausal women with breast cancer [Abstract 5075]. Retrieved December 12, 2006, from http://www.abstracts2view.com/sabcs06/view.php?nu=SABCS06L-587
22. Lenz, E.R., Pugh, L.C., Milligan, R.A., Gift, A., & Suppe, F. (1997). The middle-range Theory of Unpleasant Symptoms: An update. Advances in Nursing Science, 19(3), 14-27.
23. Lenz, E.R., Suppe, F., Gift, A.G., Pugh, L.C., & Milligan, R.A. (1995). Collaborative development of middle-range nursing theories: Toward a Theory of Unpleasant Symptoms. Advances in Nursing Science, 17(3), 1-13.
24. Lezak, M.D., Howieson, D.B., & Loring, D.W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
25. Mancuso, A., Migliorino, M., De Santis, S., Saponiero, A., & De Marinis, F. (2006). Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of Oncology, 17(1), 146-150.
26. Massa, E., Madeddu, C., Lusso, M.R., Gramignano, G., & Mantovani, G. (2006). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology/Hematology, 57(2), 175-182.
27. McCracken, L.M., & Iverson, G.L. (2001). Predicting complaints of impaired cognitive functioning in patients with chronic pain. Journal of Pain and Symptom Management, 21(5), 392-396.
28. Meyers, C.A. (2000). Neurocognitive dysfunction in cancer patients. Oncology, 14(1), 75-79.
29. Miaskowski, C., Cooper, B.A., Paul, S.M., Dodd, M., Lee, K., Aouizerat, B.E., et al. (2006). Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: A cluster analysis [Online exclusive]. Oncology Nursing Forum, 33(5), E79-E89. Retrieved March 9, 2008, from http://www.ons.org/publications/journals/onf/Volume33/Issue5/pdf/3305887.pdf
30. Miller, A.H. (2003). Cytokines and sickness behavior: Implications for cancer care and control. Brain, Behavior, and Immunity, 17(Suppl. 1), 132-134.
31. O'Shaughnessy, J. (2003). Chemotherapy-related cognitive dysfunction in breast cancer. Seminars in Oncology Nursing, 19(4, Suppl. 2), 17-24.
32. Paice, J.A. (2004). Assessment of symptom clusters in people with cancer. Journal of the National Cancer Institute. Monographs, 32, 98-102.
33. Parnet, P., Kelley, K.W., Bluthe, R.M., & Dantzer, R. (2002). Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. Journal of Neuroimmunology, 125(1-2), 5-14.
34. Peterson, S.J., & Bredow, T.S. (2004). Middle range theories. Philadelphia: Lippincott Williams and Wilkins.
35. Peyron, R., Laurent, B., & Garcia-Larrea, L. (2000). Functional imaging of brain responses to pain: A review and meta-analysis. Clinical Neurophysiology, 30(5), 263-288.
36. Pollmacher, T., Haack, M., Schuld, A., Reichenberg, A., & Yirmiya, R. (2002). Low levels of circulating inflammatory cytokines - Do they affect human brain functions? Brain, Behavior, and Immunity, 16(5), 525-532.
37. Raz, N., & Rodrigue, K.M. (2006). Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neuroscience and Biobehavioral Reviews, 30(6), 730-748.
38. Schretlen, D.J., Inscore, A.B., Jinnah, H.A., Rao, V., Gordon, B., & Pearlson, G.D. (2007). Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology, 21(1), 136-140.
39. Shumaker, S.A., Legault, C., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S., et al. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA, 291(24), 2947-2958.
40. Singh-Manoux, A., Britton, A.R., & Marmot, M. (2003). Vascular disease and cognitive function: Evidence from the Whitehall II Study. Journal of the American Geriatrics Society, 51(10), 1445-1450.
41. Tannock, I.F., Ahles, T.A., Ganz, P.A., & van Dam, F.S. (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology, 22(11), 2233-2239.
42. Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N., & Meyers, C.A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100(11), 2292-2299.
43. Wilkins, C.H., Sheline, Y.I., Roe, C.M., Birge, S.J., & Morris, J.C. (2006). Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. American Journal of Geriatric Psychiatry, 14(12), 1032-1040.
44. Wilson, C.J., Finch, C.E., & Cohen, H.J. (2002). Cytokines and cognition - The case for a head-to-toe inflammatory paradigm. Journal of the American Geriatrics Society, 50(12), 2041-2056.
45. Yaffe, K., Barnes, D., Lindquist, K., Cauley, J., Simonsick, E.M., Penninx, B., et al. (2007). Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiology of Aging, 28(2), 171-178.